surmount tirzepatide trials for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Overview of key tirzepatide clinical

There isn't strong independent clinical evidence that these additions meaningfully change outcomes versus the GLP-1 medication alone

Even some refrigerators, particularly older models or those set too cold, can create localized freezing conditions

The co-primary objectives of the study were to demonstrate that tirzepatide 10mg and/or 15mg is superior in mean percentage change in body weight from baseline and percentage of participants achieving 5% body weight reduction at 72 weeks compared to placebo

Not everyone needs the maximum dose

Always follow your doctors dosing instructions and report any side effects immediately